The 2022 National Harm Reduction Conference comes at a time when harm reduction, health care, and drug policy reform have entered a dynamic and critical phase. The prescription opioid and heroin overdose epidemic has captured national attention, with renewed focus on transmission of HIV and viral hepatitis among people who use drugs. These trends are reshaping the policy and public health landscapes, making harm reduction more urgent and relevant than ever before.
The biennial event is the only conference of its kind in the United States. For four days, some of the most creative minds from the U.S. and abroad come together to address a myriad of complex issues facing the harm reduction movement. A diverse community of people who use drugs, social justice activists, service providers, healthcare workers, researchers, policymakers, public health officials, and law enforcement— all coming together to put an end to the harms and injustices caused by the War on Drugs.
In this FREE, peer-learning
opportunity, participants will learn
from clinical experts on the cooccurrence of mental health &
substance use disorder as well as
individuals with lived experiences
with these co-morbidities &
participants will explore strategies
for grassroots organizing to
influence local & state policy
infrastructure as well as community
mobilization to meet the needs of
struggling members of our
Overdose – “What we can do to make a difference”
Presented by Co-Founders of Safe Coalition: James Derick, President Board of Directors and Jennifer Knight-Levine Executive Director.
Our presenters have firsthand, family lived experience both personally and professionally with the devastating effects of Overdose. This meeting will cover many areas of substance misuse, mental health and overdose. Our caring experts will share what the barriers to treatment have been and what we as a community can do to better support the people that we care so deeply about.
There has been growing concern of the presence of an animal tranquilizer, xylazine, that has been found in the illicit drug supply. According to the Massachusetts Drug Supply Data Stream program, 1 in 4 heroin/fentanyl samples contained xylazine!
We will be hosting a training in collaboration with the Boston Medical Center’s OBAT TTA team on the current drug trends of xylazine and how best to recognize and respond to xylazine intoxication and overdose. This training will provide important information for both public health and public safety, so all are welcome.